Mechanistic clinical trial of individualized tDCS for hallucinations in schizophrenia
个体化 tDCS 治疗精神分裂症幻觉的机制临床试验
基本信息
- 批准号:9892248
- 负责人:
- 金额:$ 19.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-12-01 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:Acoustic StimulationAcuteAffectAftercareAggressive behaviorAnatomyAnteriorAntipsychotic AgentsAttentionAuditoryAuditory Evoked PotentialsAuditory HallucinationAuditory PerceptionAuditory areaBasic ScienceBehaviorBehavioralBiological MarkersBrainCharacteristicsClinicalClinical TrialsClinical Trials DesignCognitiveComputer ModelsDataDiseaseDistressDoseEffectivenessElectrodesEtiologyFellowshipFrequenciesFunctional Magnetic Resonance ImagingFunctional disorderFutureGenerationsHallucinationsIndividualInferiorInfluentialsInsula of ReilInterventionLanguageLeftLoudnessMagnetic Resonance ImagingMeasuresMediatingModelingModificationMonitorMorbidity - disease rateNeurobiologyPaperParticipantPatient Self-ReportPatientsPerceptionPharmaceutical PreparationsPhysiologic MonitoringPhysiologicalPhysiologyPlayPre-Post TestsProfessional CompetenceProgram DevelopmentPsychotic DisordersRandomizedRefractoryReportingResearchResearch Domain CriteriaResearch PersonnelResistanceRestRoleSchizophreniaSensorySeveritiesSocial EnvironmentSourceSpecific qualifier valueStandardizationStructureSuicideSymptomsSystemTechniquesTestingTrainingTranscranial magnetic stimulationUse of New TechniquesVerbal Auditory HallucinationsWorkbaseburden of illnesscareercareer developmentdeviantelectric fieldexperiencefrontal lobeimprovedmortalityneuroimagingneuromechanismneurophysiologyneuropsychiatric disorderneuropsychiatric symptomnovelpatient orientedpotential biomarkerrelating to nervous systemresponseskillssocial deficitssuicide ratetheoriestreatment effecttreatment response
项目摘要
The large majority of patients with schizophrenia (Sz) experience auditory verbal hallucinations (AVH) as a
core feature of their disorders. AVH can be associated with increased aggression, distress, suicide rates, and
difficulty navigating the social environment. They are refractory to treatment with antipsychotics in ~30% of
patients. Physiological dysfunction of posterior auditory/language regions, such as left auditory cortex and
temporoparietal junction, and anterior language regions, such as left inferior frontal cortex and anterior insula,
is thought to play a major role in generating AVH. Noninvasive brain stimulation (NIBS) approaches such as
transcranial magnetic stimulation and transcranial direct current stimulation (tDCS) have shown promise in
treating AVH but have been difficult to reproduce often due to lack of individualized targeting and lack of target
engagement biomarkers. This project investigates individualized high-definition tDCS (HD-tDCS), a novel
technique that produces a more focal electrical field than conventional tDCS, for treatment of AVH. Inhibitory
HD-tDCS is used to test hypotheses regarding two targets, posterior (PosT) and anterior (AntT)
auditory/language regions, and their role in influencing the sensory features (e.g. loudness) and evaluative
features (e.g. salience) of AVH, respectively. Participants are randomized to receive either sham, active
conventional, active PosT, or active AntT stimulation. Individualized targeting and standardized dosing is
achieved by MR-guided computational modeling of electrical fields produced in each participant’s brain
anatomy. Furthermore, functional target engagement is verified by measuring pre/post treatment changes in
elevated resting state functional connectivity (rsFC) within and between PosT and AntT. Etiological biomarkers
that track source monitoring, prediction error, and neurophysiological abnormalities associated with AVH are
also tested pre/post treatment. The project builds on the candidate’s background in basic auditory
neurophysiology, clinical expertise in psychotic disorders and noninvasive brain stimulation, and more recent
fellowship training in basic neuroimaging and neurophysiology. The application proposes a 5-year career
development program which will provide essential and additional training in basic science of AVH, clinical trials
design and implementation, translational neuroimaging, translational neurophysiology, noninvasive brain
stimulation, and academic career skills. The acquired skills will allow the candidate to transition into an
independent patient-oriented researcher investigating individualized noninvasive brain stimulation for treatment
of neuropsychiatric symptoms and disorders. During the project he will work directly with experts in Sz, AVH,
fMRI, rsFC, aEPs, computational modeling, NIBS, and clinical trial design. The results of the proposed clinical
trial will guide future novel interventions for neuropsychiatric disorders using individualized targeting and target
engagement biomarkers. In addition the findings will have the potential to relieve the burden of illness imposed
by persistent AVH in Sz.
绝大多数精神分裂症(Sz)患者都有听觉言语幻觉(AVH)的症状
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Avissar其他文献
Michael Avissar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Avissar', 18)}}的其他基金
Mechanistic clinical trial of individualized tDCS for hallucinations in schizophrenia
个体化 tDCS 治疗精神分裂症幻觉的机制临床试验
- 批准号:
10532691 - 财政年份:2019
- 资助金额:
$ 19.25万 - 项目类别:
Mechanistic clinical trial of individualized tDCS for hallucinations in schizophrenia
个体化 tDCS 治疗精神分裂症幻觉的机制临床试验
- 批准号:
10062523 - 财政年份:2019
- 资助金额:
$ 19.25万 - 项目类别:
Mechanistic clinical trial of individualized tDCS for hallucinations in schizophrenia
个体化 tDCS 治疗精神分裂症幻觉的机制临床试验
- 批准号:
10300065 - 财政年份:2019
- 资助金额:
$ 19.25万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 19.25万 - 项目类别:
Operating Grants